russ2000_2_0298|HARP|Short Name|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
russ2000_2_0298|HARP|Long Name|Harpoon Therapeutics Inc Total Current Assets (Quarterly) (USD)|Harpoon Therapeutics Inc Cash and Short Term Investments (Quarterly) (USD)|Harpoon Therapeutics Inc Inventories (Quarterly) (USD)|Harpoon Therapeutics Inc Net PP&E (Quarterly) (USD)|Harpoon Therapeutics Inc Goodwill and Intangibles (Quarterly) (USD)|Harpoon Therapeutics Inc Total Liabilities (Quarterly) (USD)|Harpoon Therapeutics Inc Total Current Liabilities (Quarterly) (USD)|Harpoon Therapeutics Inc Total Long Term Liabilities (Quarterly) (USD)|Harpoon Therapeutics Inc Total Deposits (Quarterly) (USD)|Harpoon Therapeutics Inc Book Value (Quarterly) (USD)|Harpoon Therapeutics Inc Retained Earnings (Quarterly) (USD)|Harpoon Therapeutics Inc Treasury Stock (Quarterly) (USD)|Harpoon Therapeutics Inc EV to Revenues|Harpoon Therapeutics Inc EV to Earnings|Harpoon Therapeutics Inc EV to Free Cash Flow|Harpoon Therapeutics Inc EV to Assets (Quarterly)|Harpoon Therapeutics Inc PS Ratio|Harpoon Therapeutics Inc PE Ratio|Harpoon Therapeutics Inc Price to Book Value|Harpoon Therapeutics Inc PEG Ratio|Harpoon Therapeutics Inc Debt to Equity Ratio|Harpoon Therapeutics Inc Dividend Yield|Harpoon Therapeutics Inc Shareholder Yield (TTM)|Harpoon Therapeutics Inc Percent of Shares Outstanding Short|Harpoon Therapeutics Inc Total Receivables (Quarterly) (USD)|Harpoon Therapeutics Inc Total Payables (Quarterly) (USD)|Harpoon Therapeutics Inc Total Capital Stock (Quarterly) (USD)|Harpoon Therapeutics Inc Return on Invested Capital|Harpoon Therapeutics Inc Quality Ratio Score|Harpoon Therapeutics Inc Momentum Score|Harpoon Therapeutics Inc Beta (1Y)|Harpoon Therapeutics Inc Sustainable Growth Rate (TTM)|Harpoon Therapeutics Inc Institutional Investor Ownership Percentage|Harpoon Therapeutics Inc Average Diluted Shares Outstanding (Quarterly)|Harpoon Therapeutics Inc Total Employees (Annual)|Harpoon Therapeutics Inc EPS Diluted (Quarterly) (USD)|Harpoon Therapeutics Inc Dividend Per Share (Quarterly) (USD)|Harpoon Therapeutics Inc Revenue (Quarterly) (USD)|Harpoon Therapeutics Inc Gross Profit (Quarterly) (USD)|Harpoon Therapeutics Inc SG&A Expense (Quarterly) (USD)|Harpoon Therapeutics Inc Pre-Tax Income (Quarterly) (USD)|Harpoon Therapeutics Inc Net Income (Quarterly) (USD)|Harpoon Therapeutics Inc Net Interest Income (Quarterly) (USD)|Harpoon Therapeutics Inc Price (USD)|Harpoon Therapeutics Inc Total Return Price (USD)|Harpoon Therapeutics Inc Enterprise Value (USD)|Harpoon Therapeutics Inc 30-Day Average Daily Volume|Harpoon Therapeutics Inc 1 Year Price Returns (Daily)||
russ2000_2_0298|HARP|Unit|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
russ2000_2_0298|HARP|201712|29.647|29.423||2.087||58.815|6.916|51.899||-26.943|-35.225||||||||||0|||||1.174|0.001|||||||9.4481||-0.5229||0.708||0.912|-4.94|-4.94|0.057|||||||
russ2000_2_0298|HARP|201803||||||||||||||||||||||||||||||||||9.4481||-0.5166||1.563||0.982|-4.881|-4.881|0.073|||||||
russ2000_2_0298|HARP|201806||||||||||||||||||||||||||||||||||9.4481||-0.6344||1.063||0.967|-5.994|-5.994|0.066|||||||
russ2000_2_0298|HARP|201809|28.933|27.858||2.264||76.29|7.58|68.71||-43.983|-52.86||||||||||0|||||1.746|0.001|||||||9.4481||-0.7154||1.063||1.942|-6.759|-6.759|0.109|||||||
russ2000_2_0298|HARP|201812|90.223|89.493||2.998||156.059|11.948|144.111||-53.479|-62.591||||||||||0|||||4.357|0.001|||||||23.909|45|-0.407||1.061||2.215|-9.732|-9.732|0.147||||||13.5|13.5
russ2000_2_0298|HARP|201903|140.653|138.572||13.618||33.338|11.897|21.441||133.594|-76.17||21.6566|-2.5521|-2.7846|0.5514|32.0618||||0|0|-30.5591|0.4526||3.411|0.003|-299.4354||||-1569.877||14.7503|50|-0.92||1.063||5.832|-13.579|-13.579|0.576|9.47|9.47|92.0405|70689.1333||11.17|11.17
russ2000_2_0298|HARP|201906|137.322|133.884||19.227||34.543|14.507|20.036||122.473|-87.987||43.6149|-4.4253|-4.559|1.1805|55.3659||||0|0|-22.1346|0.4888||4.519|0.003|-105.6385||||-159.0702||24.2942|54|-0.49||1.063||3.734|-11.817|-11.817|0.84|13|13|185.3635|33803.4667||13.37|13.37
russ2000_2_0298|HARP|201909|122.991|121.227||18.876||35.157|16.686|18.471||107.231|-103.895||46.698|-4.2127|-4.6379|1.5099|64.8367||3.1355|-1.701|0|0|-21.0119|0.924||3.9|0.003|-95.9915||||-95.9915|79.4251|24.4574|55|-0.65||1.417||8.493|-15.908|-15.908|0.727|13.66|13.66|214.9975|87285.4||13.21|13.21
russ2000_2_0298|HARP|201912|150.617|148.073||18.398||82.384|22.513|59.871||94.22|-118.163||38.1286|-3.9637|-34.3794|1.2472|55.606||3.9094|-0.3475|0|0|-19.1795|1.0002||2.594|0.003|-68.7706||||-68.7706||23.3773|61|-0.58||2.234||4.332|-14.268|-14.268|0.533|14.79|14.79|220.269|150334.2||14.69|14.69
russ2000_2_0298|HARP|202003|128.697|123.097||17.893||79.202|23.814|55.388||83.294|-130.715||20.6831|-3.0377|-14.4937|1.0197|35.0372||3.4671|-0.2768|0|0|-0.0599|1.2508||1.545|0.003|-50.4288||7|1.1815|-50.4288||24.8254|67|-0.51||3.297||3.913|-12.552|-12.552|0.584|11.58|11.58|165.692|84469.8|22.2809|11.26|11.26
russ2000_2_0298|HARP|202006|174.784|171.62||17.641||125.216|39.046|86.17||71.906|-143.407||25.2223|-4.4191|6.0861|1.2424|41.7228||5.7927||0|0|0.0043|1.7785||1.586|0.003|-57.8347||10|1.4414|-57.8347|95.2118|24.9612|76|-0.51||2.762||3.945|-12.692|-12.692|0.415|16.6|16.6|244.9089|270481.4|27.6923|17.49|17.49
russ2000_2_0298|HARP|202009|||||||||||||26.3171||6.3502||42.703||5.9405|||0||3.5025||||||4|0.9142||94.8128|||||||||||16.99|16.99|255.5392|541830.9333|24.3777|16.95|16.95